2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
about
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertensionTreatment of hypertension in peripheral arterial diseaseEvolution of target organ damage and haemodynamic parameters over 4 years in patients with increased insulin resistance: the LOD-DIABETES prospective observational studyLercanidipine/enalapril combination in the management of obesity-related hypertensionAssessment and impact of diastolic function by echocardiography in elderly patientsPersonalized medicine and treatment approaches in hypertension: current perspectives2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II-treatments of hypertension2013 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology and diagnosis of hypertensionVascular Complications of Cancer ChemotherapyDiabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trialsThe metabolic vascular syndrome - guide to an individualized treatmentDiabetes Mellitus, Arterial Wall, and Cardiovascular Risk AssessmentThe Different Therapeutic Choices with ARBs. Which One to Give? When? Why?Home monitoring of blood pressureEfficacy and Safety of a Traditional Chinese Herbal Formula Xuefu Zhuyu Decoction for Hypertension: A Systematic Review and Meta-AnalysisInfluence of the Lactotripeptides Isoleucine-Proline-Proline and Valine-Proline-Proline on Systolic Blood Pressure in Japanese Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsVascular stiffness in insulin resistance and obesityPolypharmacy in Older Adults With Hypertension: A Comprehensive ReviewCardiovascular changes during chronic hypertensive statesDiastolic heart failure in hypertension: possible preventive benefits of nebivolol beyond lowering blood pressureChinese Hypertension GuidelinesAngiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?Spanish guidelines for the management of autosomal dominant polycystic kidney diseaseThe sympathetic nervous system alterations in human hypertensionAntihypertensive treatment and renal protection: the role of drugs inhibiting the renin-angiotensin-aldosterone systemNeed for better blood pressure measurement in developing countries to improve prevention of cardiovascular diseaseThe effect of black tea on blood pressure: a systematic review with meta-analysis of randomized controlled trialsCloser look at white-coat hypertensionDrug treatment of hypertension in pregnancyPharmacogenomics of hypertension and heart diseaseHome blood pressure monitoring: Australian Expert Consensus Statement.Differences between clinic blood pressure and morning home blood pressure, as shown by Bland-Altman plots, in a large observational study (HONEST study).Systolic BP and Mortality in Older Adults with CKD.Hypertension and Angiotensin System Inhibitors in Patients with Metastatic Renal Cell CarcinomaTarget Blood Pressure in Patients with Diabetes: Asian PerspectiveThe Role of Home Blood Pressure Telemonitoring for Blood Pressure ControlSodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic ReviewAortic Stiffness as a Surrogate Endpoint to Micro- and Macrovascular Complications in Patients with Type 2 DiabetesVascular Disease in Young Indians (20-40 years): Role of HypertensionEffects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction Risk
P2860
Q24186647-AB6AFC0F-5CF8-4A89-AB2D-CE4BCB457FCEQ24201969-4DFAE0FB-97FF-4D17-9BF9-3CDC29C03A93Q24658535-A8862D99-540B-4306-A677-3DEC3D689252Q26749941-ADB042FA-9620-49BE-BF1D-78C5066DCEB6Q26751096-26A27537-C528-4606-B190-0129A96E7BA7Q26751135-0CED1BF8-A4D7-4127-B530-DA2B0C3AB9A3Q26764784-8125C47F-0C97-48BA-8AEA-ADF3960D1CB3Q26764788-EFA40CDE-B8E4-4D2D-A588-3BB033482EB1Q26766269-D1969124-6B82-4D86-8C5F-BDCE92ED7833Q26766599-687B23E1-C02E-4393-99B6-50776EEBE61BQ26767142-9F24F2F3-010F-40BE-A6B3-10B6B30393D2Q26767215-2CD9C451-01FD-4A79-B707-F6B1AA6A89D6Q26768696-2A7BC843-04C5-402F-B0EA-EDACABEBB1C7Q26773362-45F31523-DDAB-41B5-954B-2A83B804A037Q26779863-7824C3EC-D6F2-4A12-B5D9-B5EC908431DCQ26780236-6530E45F-A092-42C1-A115-BA817C98901CQ26796220-2A81C1A3-36D5-46C0-8B0B-0509C41A248BQ26799236-6BE2F4A1-B932-48F0-9B71-F6E332936477Q26827799-056068D9-F5A0-4C53-A52D-4F93A5AA54A5Q26849309-235A96F4-8591-47BD-8184-58FF4DDD8510Q26851095-A78DD086-70FA-4740-B0F9-CFFF456E3477Q26851803-17EEB4B0-AC0E-4160-959D-EA18D09F1A2EQ26863397-FD311F13-358B-4525-B37E-42F5E3195959Q26863516-F2459F0B-BF0F-4C99-A2BA-FBBB8045D6DAQ26865691-F04A8E5F-DDBE-45A8-A269-99E60679E84DQ26866002-8F4547FB-3F88-4F86-B139-C0C790287B36Q26999806-E80400BF-170B-4C62-B3E8-0A3FD2CF811EQ27014664-9A0BA813-8EA0-45E5-864C-1ED06DCD96BEQ27014718-ACB37C34-7705-42E3-BF33-5EA5FDBC42BFQ27015722-2591CCE9-CA1D-42E7-B78C-5E1FB74CF5A5Q27024621-BF397ACC-E334-4F05-8604-8EE23B0F0DD9Q27323117-88FB8A32-6862-41CD-8072-0E38809C6439Q27335475-330B4C34-1F40-4F36-8388-E88BFF9F635DQ28066747-8C10B840-AB11-4E8E-924F-0745E042A017Q28067966-77C46484-92A3-4E49-B079-87C8BC13A0E3Q28069756-93F16CE2-5873-45F2-8535-9E7CFDA11CDEQ28072352-7CB45A75-4664-4E0A-B84A-8B558F97A8CDQ28074239-B8D95724-F8BF-41CA-B8A7-53F8CEEF0CFCQ28074249-8A922880-BF4C-4E2A-9A06-EEBB6CD6C865Q28076223-47A76188-B01E-4844-866D-7AB4E08FDDE7
P2860
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
2013 ESH/ESC Guidelines for th ...... n Society of Cardiology (ESC).
@en
2013 ESH/ESC Guidelines for th ...... ropean Society of Hypertension
@nl
type
label
2013 ESH/ESC Guidelines for th ...... n Society of Cardiology (ESC).
@en
2013 ESH/ESC Guidelines for th ...... ropean Society of Hypertension
@nl
prefLabel
2013 ESH/ESC Guidelines for th ...... n Society of Cardiology (ESC).
@en
2013 ESH/ESC Guidelines for th ...... ropean Society of Hypertension
@nl
P2093
P50
P1476
2013 ESH/ESC Guidelines for th ...... n Society of Cardiology (ESC).
@en
P2093
Athanasios J Manolis
Bernard Waeber
Josep Redón
Margus Viigimaa
Michael Böhm
Peter M Nilsson
Peter Sleight
Robert Fagard
Stéphane Laurent
Task Force Members
P304
P356
10.1097/01.HJH.0000431740.32696.CC
P50
P577
2013-07-01T00:00:00Z